Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Le Infezioni in Medicina|June 17, 2026
Insights into parvovirus B19 clinical and virological dynamics among blood donorsMassimo La Raja, Nicola Benvenuto, Monica Marconi, et al.
Cancer|July 27, 2004
Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort studyMassimo Offidani, Laura Corvatta, Lara Malerba, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|April 15, 2003
High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemiaMassimo Offidani, Laura Corvatta, Riccardo Centurioni, et al.
Leukemia & Lymphoma|December 29, 2004
Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL)Massimo Offidani, Laura Corvatta, Lara Malerba, et al.
European Journal of Haematology|February 9, 2007
Thalidomide-dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide-dexamethasone: a case-matched study in advanced multiple myelomaMassimo Offidani, Sara Bringhen, Laura Corvatta, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|August 7, 2004
Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myelomaMassimo Offidani, Laura Corvatta, Monica Marconi, et al.
European Journal of Haematology|May 7, 2004
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathyMassimo Offidani, Laura Corvatta, Monica Marconi, et al.
British Journal of Haematology|January 20, 2007
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scansAnna Mele, Massimo Offidani, Giuseppe Visani, et al.
Clinical Lymphoma & Myeloma|October 16, 2008
Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapyMassimo Offidani, Laura Corvatta, Claudia Polloni, et al.
British Journal of Haematology|November 28, 2008
Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised studyMassimo Offidani, Laura Corvatta, Claudia Polloni, et al.
Pageof 2